Literature DB >> 31728695

Impact of an HIV Care Coordination Program on the Timeliness of Viral Suppression and Immune Recovery Among Clients Newly Diagnosed with HIV.

McKaylee M Robertson1,2, Kate Penrose3, Denis Nash4,5, Graham Harriman3, Sarah L Braunstein3, Bruce Levin6, Mary K Irvine3.   

Abstract

We compared the time to immune recovery and viral suppression (VS) among people newly diagnosed with HIV who enrolled in the HIV Care Coordination Program (CCP), a comprehensive medical case management program, with a propensity matched group of newly diagnosed people who did not enroll. CCP enrollees had more rapid VS (≤ 200 copies/mL) [hazards ratio (HR) 1.17; 95% confidence interval 1.02-1.34] but no more rapid immune recovery (≥ two successive CD4 counts > 500 cells/mm3) (HR 0.98; 0.84-1.13). Relative to usual care, the CCP may expedite VS (though not immune recovery) for newly diagnosed HIV patients and therefore lower forward transmission risk.

Entities:  

Keywords:  Care coordination; Comparative effectiveness; HIV; Immunologic recovery; Medical case management; New HIV diagnoses; Viral suppression

Mesh:

Year:  2020        PMID: 31728695      PMCID: PMC7735065          DOI: 10.1007/s10461-019-02732-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  12 in total

Review 1.  Immunological recovery and antiretroviral therapy in HIV-1 infection.

Authors:  Manuel Battegay; Reto Nüesch; Bernard Hirschel; Gilbert R Kaufmann
Journal:  Lancet Infect Dis       Date:  2006-05       Impact factor: 25.071

2.  Using Registry Data to Construct a Comparison Group for Programmatic Effectiveness Evaluation: The New York City HIV Care Coordination Program.

Authors:  McKaylee M Robertson; Levi Waldron; Rebekkah S Robbins; Stephanie Chamberlin; Kate Penrose; Bruce Levin; Sarah Kulkarni; Sarah L Braunstein; Mary K Irvine; Denis Nash
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

3.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

4.  Timeliness of Human Immunodeficiency Virus Diagnosis and Antiretroviral Treatment Initiation in the Era of Universal Testing and Treatment.

Authors:  McKaylee M Robertson; Sarah L Braunstein; Donald R Hoover; Sheng Li; Denis Nash
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

5.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

6.  All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

Authors:  Charlotte Lewden; Vincent Bouteloup; Stéphane De Wit; Caroline Sabin; Amanda Mocroft; Jan Christian Wasmuth; Ard van Sighem; Ole Kirk; Niels Obel; George Panos; Jade Ghosn; François Dabis; Murielle Mary-Krause; Catherine Leport; Santiago Perez-Hoyos; Paz Sobrino-Vegas; Christoph Stephan; Antonella Castagna; Andrea Antinori; Antonella d'Arminio Monforte; Carlo Torti; Cristina Mussini; Virginia Isern; Alexandra Calmy; Ramón Teira; Matthias Egger; Jesper Grarup; Geneviève Chêne
Journal:  Int J Epidemiol       Date:  2011-11-28       Impact factor: 7.196

7.  Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program.

Authors:  Mary K Irvine; Stephanie A Chamberlin; Rebekkah S Robbins; Julie E Myers; Sarah L Braunstein; Beau J Mitts; Graham A Harriman; Fabienne Laraque; Denis Nash
Journal:  Clin Infect Dis       Date:  2014-10-09       Impact factor: 9.079

8.  Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics.

Authors:  Lytt I Gardner; Thomas P Giordano; Gary Marks; Tracey E Wilson; Jason A Craw; Mari-Lynn Drainoni; Jeanne C Keruly; Allan E Rodriguez; Faye Malitz; Richard D Moore; Lucy A Bradley-Springer; Susan Holman; Charles E Rose; Sonali Girde; Meg Sullivan; Lisa R Metsch; Michael Saag; Michael J Mugavero
Journal:  Clin Infect Dis       Date:  2014-05-15       Impact factor: 9.079

9.  Implementation of a Rapid Entry Program Decreases Time to Viral Suppression Among Vulnerable Persons Living With HIV in the Southern United States.

Authors:  Jonathan Colasanti; Jeri Sumitani; C Christina Mehta; Yiran Zhang; Minh Ly Nguyen; Carlos Del Rio; Wendy S Armstrong
Journal:  Open Forum Infect Dis       Date:  2018-06-28       Impact factor: 3.835

10.  Short-term effectiveness of HIV care coordination among persons with recent HIV diagnosis or history of poor HIV outcomes.

Authors:  Denis Nash; McKaylee M Robertson; Kate Penrose; Stephanie Chamberlin; Rebekkah S Robbins; Sarah L Braunstein; Julie E Myers; Bisrat Abraham; Sarah Kulkarni; Levi Waldron; Bruce Levin; Mary K Irvine
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

View more
  1 in total

1.  HIV Care Coordination promotes care re-engagement and viral suppression among people who have been out of HIV medical care: an observational effectiveness study using a surveillance-based contemporaneous comparison group.

Authors:  Mary K Irvine; McKaylee M Robertson; Denis Nash; Sarah G Kulkarni; Sarah L Braunstein; Bruce Levin
Journal:  AIDS Res Ther       Date:  2021-10-12       Impact factor: 2.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.